IDEXX LABORATORIES INC /DE
(IDXX)CIK 874716 · SEC filings only
harness minimum not met
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (1)
Outlook assumes ~$1.5 billion of share repurchases in 2025
grade
Resolved promises
Full say-do history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance shown, not graded (23)
These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.
- eps guidance fy · Aug 4, 2026Increases 2026 EPS outlook to $14.69 - $14.94Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 2, 2026Projects 2026 EPS of $14.29 - $14.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 3, 2025Raises 2025 EPS outlook to $12.81 - $13.01Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 4, 2025Updates 2025 EPS outlook to $12.40 - $12.76Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 1, 2025Updates 2025 EPS outlook to $11.93 - $12.43Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 3, 2025Estimates 2025 EPS of $11.74 - $12.24Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 31, 2024Narrows 2024 EPS outlook to $10.37 - $10.53Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 6, 2024Adjusts 2024 EPS outlook to $10.31 - $10.59Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 1, 2024Updates 2024 EPS outlook to $10.82 - $11.20Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 5, 2024Estimates 2024 EPS of $10.84 - $11.33Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 1, 2023Updates 2023 EPS outlook to $9.74 - $9.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 1, 2023Increases 2023 EPS outlook to $9.64 - $9.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 2, 2023Updates 2023 EPS outlook to $9.33 - $9.75Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 6, 2023Estimates 2023 EPS of $9.27 - $9.75Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 1, 2022The Company's EPS outlook of $7.74 - $7.98Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 2, 2022The Company's EPS outlook of $7.77 - $8.05Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 4, 2022The Company's EPS outlook of $8.11 - $8.35Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 2, 2022Estimates 2022 EPS of $9.27 - $9.59Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 2, 2021EPS $8.30 - $8.38Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 30, 2021Raises 2021 EPS outlook to $8.20 - $8.36Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 4, 2021Raises 2021 EPS outlook to $7.88 - $8.18Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 2, 2021Estimates 2021 EPS of $7.39 - $7.71Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 1, 2019We are increasing our 2019 EPS outlook to $4.66 - $4.78 per shareUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
Open promises (4) · 18 superseded
Adjusts 2024 revenue guidance to $3,865 million - $3,890 million
Increases 2025 revenue guidance to $4,270 million - $4,300 million
Narrows 2026 revenue guidance to $4,700 million - $4,745 million
Increases 2023 revenue guidance to $3,615 million - $3,700 million
Provides initial outlook for 2023 revenue of $3,590 million - $3,690 million
Provides initial outlook for 2025 revenue of $4,055 million - $4,170 million
Provides initial outlook for 2021 revenue of $3,065 million - $3,120 million
Provides initial outlook for 2024 revenue of $3,930 million - $4,040 million
The Company is updating its full year revenue growth outlook to 3% - 5.5% as reported and 5.5% - 8% organically
Provides initial outlook for 2026 revenue guidance range of $4,632 million - $4,720 million
Adjusts 2025 revenue guidance to $4,095 million - $4,210 million
Increases 2021 revenue guidance to $3,170 million - $3,205 million
Updates 2023 revenue guidance to $3,660 million - $3,715 million
Provides initial outlook for 2022 revenue of $3,500 million - $3,565 million
Updates 2024 revenue guidance to $3,885 million - $3,945 million
Updates guidance for 2025 reported revenue growth to 7.7% - 9.7%
Re-calibrated 2022 revenue outlook reflects 5.5% - 8% reported growth
Increases 2021 revenue guidance to $3,105 million - $3,160 million
Updates 2024 revenue guidance to $3,895 million - $3,965 million
Updates guidance for 2025 reported revenue growth to 5% - 8%
Increases 2025 revenue guidance to $4,205 million - $4,280 million
Credibility timeline
Timeline as a list
- Feb 14, 2020KEPTThe Company is reaffirming its 2019 revenue outlook of $2,385 million - $2,425 million
- Feb 16, 2022BEATRevenue $3,185 - $3,200
- Feb 16, 2023BEATThe Company is updating its full-year revenue growth outlook to 3.5% - 4.5% as reported and 6.5% - 7.5% organically.
- Feb 22, 2024BEATAdjusts 2023 revenue guidance to $3,635 million - $3,650 million
- Feb 21, 2025BEATUpdates 2024 revenue growth guidance to 5.5% - 6.2% as reported
- Feb 20, 2026BEATUpdates outlook for 2025 reported revenue growth of 9.6% - 10.3%